Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Checking blood markers in people with type 2 diabetes after blood sugar control

Studies how a blood test measure relates to HbA1C in adults with type 2 diabetes.

Plain-language title generated from the registry record
Registry title: Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control

Key facts

Where
Al Khārjah, EgyptSee the site

Where in Egypt

  • New Valley University- Faculty of MedicineAl Khārjah, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
New Valley University
Trial code
NCT06067399
Record updated
30 July 2026
Original description
Diabetes mellitus (DM) is an epidemic disease, with approximately 463 million persons diagnosed with it. Of those, 90% are patients with type 2 DM (T2DM). Some estimates indicate that 700 million cases of DM will be reported in 2045. T2DM develops due to insulin resistance, leading to reduced insulin secretion. DM has a number of associated complications, such as nephropathy, neuropathy, and cardiovascular disease.Read full original descriptionShow less

Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control

Diabetes mellitus (DM) is an epidemic disease, with approximately 463 million persons diagnosed with it. Of those, 90% are patients with type 2 DM (T2DM). Some estimates indicate that 700 million cases of DM will be reported in 2045. T2DM develops due to insulin resistance, leading to reduced insulin secretion. DM has a number of associated complications, such as nephropathy, neuropathy, and cardiovascular disease.

Inclusion: Patients diagnosed to have Uncontrolled type 2 diabetes mellitus (HbA1C more than 7%).

Exclusion: Patients diagnosed to have type 1 diabetes; Patients are diagnosed to have secondary diabetes; Clinical states associated with increased RDW:; Anemia (Female Hb less than 12, Male Hb less than 13) either due to hemolysis, or in response to ineffective red cell production, which can be caused by deficiencies in iron, vitamin B12 or folate; After blood transfusions; Pregnancy, thrombotic thrombocytopenic purpura and inflammatory bowel disease.

ClinicalTrials.gov NCT06067399